Prosecution Insights
Last updated: April 19, 2026

Janssen Research & Development LLC

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18752571 PLATFORM FOR MANAGING CONTEXTUAL AVAILABILITY OF ELECTRONIC HEALTH DATA VAN DUZER, ALEXIS KIM 3681 Non-Final OA Jun 24, 2024
18706576 LIGHT-BASED VISUAL CUEING OF MEDICATION DELIVERY INSTRUCTIONS USING LIGHT AND MOTION SENSORS POLLOCK, ZACHARY JOSEPH 3715 Non-Final OA May 01, 2024
18694042 HIGH-DOSE COMPRESSIBLE DOSAGE FORMS MANUFACTURED BY SIMULTANEOUS MELT-COATING AND MELT-GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS TCHERKASSKAYA, OLGA V 1615 Non-Final OA Mar 21, 2024
18689855 Selecting Clinical Trial Sites Based on Multiple Target Variables Using Machine Learning MPAMUGO, CHINYERE 3685 Non-Final OA Mar 06, 2024
18376817 METHOD AND SYSTEM FOR HYBRID CLINICAL TRIAL DESIGN GEDRA, OLIVIA ROSE 3681 Final Rejection Oct 04, 2023

Managing Janssen Research & Development LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month